BDX three-lens brief
Evidence-based stock research on BDX. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved -2.21% yesterday. · Underperforming SPY by 21.6pp over 30 days.
- Moved -2.21% yesterday.
- Underperforming SPY by 21.6pp over 30 days.
- Analyst mean target $183.29 — 27% above current (14 analysts).
- Debt-to-equity of 71.6 — balance-sheet-heavy.
BDX closed at $144.25 (-2.21%) as of 2026-05-13. Market cap: $39.75B. P/E (trailing) 25.2. Positives: analyst mean target $183.29 — 27% above current (14 analysts).. Concerns: moved -2.21% yesterday.; underperforming SPY by 21.6pp over 30 days.. Last quarter: Revenue $4.71B, net income -$311.00M, free cash flow $4.53B.
Why three lenses on BDX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BDXacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BDX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BDX brief"></iframe>